INBX
Price
$11.95
Change
-$0.21 (-1.73%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
176.03M
34 days until earnings call
SNTI
Price
$4.87
Change
+$0.44 (+9.93%)
Updated
Apr 24, 04:58 PM (EDT)
Capitalization
105.06M
Ad is loading...

INBX vs SNTI

Header iconINBX vs SNTI Comparison
Open Charts INBX vs SNTIBanner chart's image
Inhibrx Biosciences
Price$11.95
Change-$0.21 (-1.73%)
Volume$721
Capitalization176.03M
Senti Biosciences
Price$4.87
Change+$0.44 (+9.93%)
Volume$500
Capitalization105.06M
INBX vs SNTI Comparison Chart
Loading...
INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INBX vs. SNTI commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INBX is a Hold and SNTI is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (INBX: $12.16 vs. SNTI: $4.43)
Brand notoriety: INBX and SNTI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INBX: 45% vs. SNTI: 77%
Market capitalization -- INBX: $176.03M vs. SNTI: $105.06M
INBX [@Biotechnology] is valued at $176.03M. SNTI’s [@Biotechnology] market capitalization is $105.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INBX’s FA Score shows that 2 FA rating(s) are green whileSNTI’s FA Score has 0 green FA rating(s).

  • INBX’s FA Score: 2 green, 3 red.
  • SNTI’s FA Score: 0 green, 5 red.
According to our system of comparison, INBX is a better buy in the long-term than SNTI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INBX’s TA Score shows that 5 TA indicator(s) are bullish while SNTI’s TA Score has 5 bullish TA indicator(s).

  • INBX’s TA Score: 5 bullish, 5 bearish.
  • SNTI’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, INBX is a better buy in the short-term than SNTI.

Price Growth

INBX (@Biotechnology) experienced а +6.02% price change this week, while SNTI (@Biotechnology) price change was +15.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

INBX is expected to report earnings on May 28, 2025.

SNTI is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INBX($176M) has a higher market cap than SNTI($105M). SNTI YTD gains are higher at: 26.211 vs. INBX (-21.039). INBX has higher annual earnings (EBITDA): 1.72B vs. SNTI (-57.12M). INBX has more cash in the bank: 196M vs. SNTI (10.5M). INBX has less debt than SNTI: INBX (1.84M) vs SNTI (34.7M). INBX has higher revenues than SNTI: INBX (1.57M) vs SNTI (0).
INBXSNTIINBX / SNTI
Capitalization176M105M168%
EBITDA1.72B-57.12M-3,015%
Gain YTD-21.03926.211-80%
P/E Ratio0.11N/A-
Revenue1.57M0-
Total Cash196M10.5M1,867%
Total Debt1.84M34.7M5%
TECHNICAL ANALYSIS
Technical Analysis
INBXSNTI
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
65%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
52%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
57%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
60%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
51%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
75%
Declines
ODDS (%)
Bearish Trend 9 days ago
84%
Bearish Trend 21 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
56%
Aroon
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
72%
View a ticker or compare two or three
Ad is loading...
INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MNNCX30.85N/A
N/A
Victory Munder Multi-Cap C
MAEGX12.45N/A
N/A
BlackRock Unconstrained Equity Instl
JBGCX44.36N/A
N/A
JHancock Blue Chip Growth C
ADLVX26.24N/A
N/A
Adler Value Institutional
FCEEX10.25N/A
N/A
Franklin Emerging Market Core Equity Adv

INBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, INBX has been loosely correlated with AXON. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if INBX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INBX
1D Price
Change %
INBX100%
+2.44%
AXON - INBX
48%
Loosely correlated
+3.82%
AKESF - INBX
45%
Loosely correlated
+13.21%
SNTI - INBX
39%
Loosely correlated
+9.65%
RAPT - INBX
38%
Loosely correlated
+5.93%
VCYT - INBX
37%
Loosely correlated
+1.08%
More

SNTI and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNTI has been loosely correlated with PPBT. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if SNTI jumps, then PPBT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNTI
1D Price
Change %
SNTI100%
+9.65%
PPBT - SNTI
56%
Loosely correlated
-7.21%
TCRT - SNTI
47%
Loosely correlated
+2.92%
INBX - SNTI
41%
Loosely correlated
+2.44%
VERV - SNTI
33%
Poorly correlated
+3.81%
PTCT - SNTI
33%
Poorly correlated
+3.65%
More